EFA® technology

March 17, 2020

EFA® in Cystic Fibrosis

The ACPCF conference in Glasgow introduces KALOS MPR is glad to announce that our provider in UK promoted KALOS at the ACPCF congress on 12-13th March […]
December 10, 2019

EFA® versus PEP

Rehabilitation protocols in COPD patients Two clinical trials, comparing EFA® technology with PEP exercises, both in association with a pulmonary rehabilitation program, have been published. Airway […]
October 14, 2019

EFA® in tracheostomised patients

A recent study shows that EFA® technology is a suitable support for the non-invasive management of pulmonary secretions in tracheostomised patients. Published on the Clinical Respiratory […]
July 8, 2019
ERS 2019 Madrid

MPR in Madrid: ERS 2019

MPR is pleased to announce its participation in the ERS International Congress 2019, a showcase of excellence across the entire field of respiratory medicine. This year […]
May 29, 2019
EFA technology in pediatrics

EFA® technology in paediatrics

A pilot study investigates the effectiveness of the Free Aspire device in the management of bronchial secretions and highlights its positive response in paediatrics patients with […]
April 1, 2019
Congresso Internazionale sulla fisioterapia respiratoria - respiratory rehabilitation

Respiratory rehabilitation

the new product TPEP® 4, designed to perform respiratory rehabilitation exercises, was officially presented at the Congress.
December 7, 2018

KALOS cough assist

Kalos is the innovative cough assistant designed to provide an optimal solution in the management of tracheobronchial secretions.